phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Seizures in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bihel, F; Boon, P; Bourguignon, JJ; Buffel, I; De Herdt, V; De Meulenaere, V; Meurs, A; Poppe, L; Portelli, J; Raedt, R; Schmitt, M; Simonin, F; Smolders, I; Vonck, K; Wadman, W | 1 |
1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Seizures
| Article | Year |
|---|---|
The effect of neuropeptide FF in the amygdala kindling model.
Topics: Amygdala; Animals; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Kindling, Neurologic; Male; Oligopeptides; Rats; Rats, Wistar; Seizures | 2016 |